SCHEMBL4466176

SCHEMBL4466176

Cc1ccc(C=C(CC(=O)N2CC3CC=CCC3C2)C(=O)O)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
CYP2C19 P33261 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GPR183 P32249 1/20 0.34
GRIN2B Q13224 2/20 0.34
HTT P42858 1/20 0.34
GRIK1 P39086 1/20 0.33
HSD11B1 P28845 1/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
USP2 O75604 1/20 0.33
AKR1C3 P42330 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4466165 1.00 ALDH1A1 (0.36) ALDH1A1HPGDCYP2C19NPC1RAB9A
SCHEMBL4466167 1.00 ALDH1A1 (0.36) ALDH1A1HPGDCYP2C19NPC1RAB9A
SCHEMBL4466177 1.00 ALDH1A1 (0.36) ALDH1A1HPGDCYP2C19NPC1RAB9A
SCHEMBL4466172 1.00 ALDH1A1 (0.36) ALDH1A1HPGDCYP2C19NPC1RAB9A
SCHEMBL9046361 0.88 CYP3A4 (0.44) ALDH1A1HPGDKDM4EAKR1C3CYP3A4
SCHEMBL9046349 0.88 CYP3A4 (0.44) ALDH1A1HPGDKDM4EAKR1C3CYP3A4
SCHEMBL9046355 0.88 CYP3A4 (0.44) ALDH1A1HPGDKDM4EAKR1C3CYP3A4
SCHEMBL9046398 0.88 CYP3A4 (0.44) ALDH1A1HPGDKDM4EAKR1C3CYP3A4
SCHEMBL9046368 0.88 CYP3A4 (0.44) ALDH1A1HPGDKDM4EAKR1C3CYP3A4
SCHEMBL9045993 0.88 ALDH1A1 (0.40) ALDH1A1HPGDCYP2C19NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 EP claimed
EP-1931359-A4 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION ELIXIR PHARMACEUTICALS INC (US) 2009-04-01 EP disclosed
EP-1931359-A2 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION Elixir Pharmaceuticals, Inc. (US) 2008-06-18 EP disclosed
WO-2007033292-A2 COMBINATION THERAPY FOR CONTROLLED CARBOHYDRATE DIGESTION ELIXIR PHARMACEUTICALS, INC. (US) 2007-03-22 WO disclosed
EP-0507534-B1 Succinic acid compounds KISSEI PHARMACEUTICAL (JP) 1996-02-28 EP disclosed
US-5202335-A Hypoglycemic, antidiabetic agents KISSEI PHARMACEUTICAL CO., LTD. (JP) 1993-04-13 US disclosed
EP-0507534-A1 Succinic acid compounds KISSEI PHARMACEUTICAL CO., LTD. (JP) 1992-10-07 EP disclosed